Borrega García, Pablo | Oncología

Resultados: 35
Tipo Título / Nombre Autor(es) Año
ECO-SEOM-SEEO safety recommendations guideline for cancer patients receiving intravenous therapy Magallón-Pedrera I, Pérez-Altozano J, Virizuela Echaburu JA, Beato-Zambrano C, Borrega-García P, de la Torre-Montero JC 2020
Análisis fenotípico de familias con síndrome de cáncer de mama y ovario hereditario no-BRCA González-Santiago S, Corcho M, Alonso S, López de Ceballos MH, Garcia JA, Romero S, Salgado M, Fernández L, Borrega P 2019
Correlation between toxicities and outcomes during treatment with immune checkpoint inhibitors in non-small cell lung cancer patients Ayala de Miguel P, Arnáiz Díez S, Gorospe García I, López Gallego J, Illán Varella A, Borrega García P 2019
Hyperprogressive disease in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors Ayala de Miguel P, López Gallego J, Gorospe García I, Illán Varella A, Rivera Vargas PR, Posada Restrepo A, Borrega García P 2019
Diferenciación neuroendocrina de células pequeñas de adenocarcinoma de próstata en paciente con mutación en BRCA-2 Ayala de Miguel P, Gorospe García I, Illán Varella A, López Gallego J, Borrega García P 2019
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer Castro E, Romero-Laorden N, Del Pozo A, Lozano R, Medina A, Puente J, Piulats JM, Lorente D, Sáez M, Morales-Barrera R, González-Billalabeitia E, Cendón Y, García-Carbonero I, Borrega P, Méndez Vidal MJ, Montesa A, Nombela P, Fernández-Parra E, González Del Alba A, Villa-Guzmán JC, Ibáñez K, Rodríguez-Vida A, Magraner-Pardo L, Pérez-Valderrama B, Vallespín E, Gallardo E, Vázquez S, Pritchard CC, Lapunzina P, Olmos D 2019
Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study Manso L, Moreno Antón F, Izarzugaza Perón Y, Delgado Mingorance JI, Borrega García P, Echarri González MJ, Martínez-Jañez N, López-González A, Olier Garate C, Ballesteros García A, Chacón López-Muñíz I, Ciruelos Gil E, García-Sáenz JA, Paz-Ares L 2019
Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor-Targeted Agents Angelergues A, Efstathiou E, Gyftaki R, Wysocki PJ, Lainez N, Gonzalez I, Castellano DE, Ozguroglu M, Carbonero IG, Flechon A, Borrega P, Guillot A, Balea BC, Le Moulec S, Esteban E, Munarriz J, Rubio G, Birtle AJ, Delanoy N, Bellmunt J, Oudard S 2018
Urgencias oncológicas De vIsu...¡a jugaaar! Borrega García P 2018
First interim results of the radium-223 (Ra-223) REASSURE observational study: Analysis of patient (Pt) characteristics and safety by use of abiraterone and/or enzalutamide (Abi/Enza) Harshman LC, Logue J, Sternberg CN, Sundar S, Schrijvers D, Schostak M, Sylvester J, George S, Tucci M, Borrega P, Ziem P, Concepción R, 2017